Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Claudio Montuori
Observed name:
C Montuori
Institutions:
Università Cattolica del Sacro Cuore,
University of Perugia,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
University of Perugia,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0003-2070-0314
Observed ORCID:
0000-0003-2070-0314
OpenAlex ID:
A5033912543
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps ( CRSwNP ): A multicentric observational Phase IV real‐life study ( DUPIREAL )
2023
·
Eugenio De Corso
, Ernesto Pasquini
, et al.
·
Allergy
·
196
PDF
Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment
2022
·
Eugenio De Corso
, Stefano Settimi
, et al.
·
Journal of Clinical Medicine
·
86
PDF
Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study
2022
·
Stefania Gallo
, Paolo Castelnuovo
, et al.
·
Journal of Personalized Medicine
·
62
PDF
Efficacy of Biologics on Refractory Eosinophilic Otitis Media Associated with Bronchial Asthma or Severe Uncontrolled CRSwNP
2022
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
Journal of Clinical Medicine
·
44
PDF
Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making
2023
·
Josje Otten
, Rik van der Lans
, et al.
·
Expert Review of Clinical Immunology
·
41
Sinonasal Biomarkers Defining Type 2-High and Type 2-Low Inflammation in Chronic Rhinosinusitis with Nasal Polyps
2022
·
Eugenio De Corso
, Silvia Baroni
, et al.
·
Journal of Personalized Medicine
·
40
PDF
Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP
2024
·
Cecilia Rosso
, Eugenio De Corso
, et al.
·
European Archives of Oto-Rhino-Laryngology
·
32
PDF
How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review
2023
·
Eugenio De Corso
, Stefano Settimi
, et al.
·
Acta Otorhinolaryngologica Italica
·
31
PDF
Two‐Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage
2025
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
Allergy
·
29
Comparative real‐world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patients
2024
·
Eugenio De Corso
, Davide Paolo Porru
, et al.
·
Clinical Otolaryngology
·
26
PDF
Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab
2023
·
Giancarlo Ottaviano
, Eugenio De Corso
, et al.
·
Journal of Personalized Medicine
·
25
PDF
Blood and local nasal eosinophilia in chronic rhinosinusitis with nasal polyps: prevalence and correlation with severity of disease
2025
·
Eugenio De Corso
, Marco Corbò
, et al.
·
Acta Otorhinolaryngologica Italica
·
21
PDF
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study
2023
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
European Archives of Oto-Rhino-Laryngology
·
20
Is There Any Reliable Predictor of Functional Recovery Following Post‐thyroidectomy Vocal Fold Paralysis?
2022
·
Luca Revelli
, Pierpaolo Gallucci
, et al.
·
World Journal of Surgery
·
16
PDF
Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment
2022
·
Sara Torretta
, Eugenio De Corso
, et al.
·
Journal of Personalized Medicine
·
13
PDF
Dupilumab Monthly Dose De‐Escalation Maintains Efficacy in CRSwNP : A Two‐Year Real‐World Study
2025
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
The Laryngoscope
·
10
Real-Life Experience in the Management of Sinonasal Complications of Dental Disease or Treatments
2022
·
Eugenio De Corso
, Mario Rigante
, et al.
·
Journal of Personalized Medicine
·
8
PDF
One year mepolizumab outcomes in severe, uncontrolled CRSwNP: a real-life study.
2025
·
E De Corso
, M Corbi
, et al.
·
PubMed
·
7
Dupilumab-Induced Blood Eosinophilia in Patients With Chronic Rhinosinusitis With Nasal Polyps: Temporal Trends and Correlation With Adverse Events
2025
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
7
Strategies for Tapering the Dosage of Biologics Targeting Type 2 Inflammation: A Systematic Review
2025
·
Antonella Loperfido
, Claudio Montuori
, et al.
·
Current Allergy and Asthma Reports
·
6
Chronic Rhinosinusitis Optimisation of Nasal Outcomes and Scores (CHRONOS): An Italian Delphi Consensus on Long-Term Management with Biologics
2026
·
Eugenio De Corso
, Frank Rikki Mauritz Canevari
, et al.
·
Current Allergy and Asthma Reports
·
5
When hypereosinophilia occurs during dupilumab therapy: evidence-based strategies for clinical management in respiratory indications
2025
·
Marco Caminati
, Andrea Portacci
, et al.
·
Expert Review of Respiratory Medicine
·
5
Assessment of the extent of previous endoscopic sinus surgery using the ACCESS score in patients with chronic rhinosinusitis referred to tertiary care rhinologic clinics
2026
·
M Lazzeroni
, R Hoven
, et al.
·
Rhinology Journal
·
3
Influence of Multiple Prior Endoscopic Sinus Surgeries on Dupilumab Efficacy Including Smell Function in the DUPIREAL Population
2025
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
Clinical Otolaryngology
·
3
Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial
2026
·
Eugenio De Corso
, Giancarlo Ottaviano
, et al.
·
The Lancet Respiratory Medicine
·
1
Show more works
View as search
Works count:
27
Citation count:
738
H-index:
14
I10-index:
16
Year
Topic
Type